A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with...

por Smith, Keisha, Pace, Amy, Ortiz, Stephan, Kazani, Shamsah, Rottinghaus, Scott
Publicado 2020

Do Progestin-Only Contraceptives Contribute to the Risk of Developing Depression as Implied by Beta-Arrestin 1 Levels in Leukocytes? A Pilot Study

por Smith, Keisha, Nayyar, Sanket, Rana, Tanu, Archibong, Anthony E., Looney, Kimberly R., Nayyar, Tultul
Publicado 2018

Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer

por Schwab, Luciana P, Peacock, Danielle L, Majumdar, Debeshi, Ingels, Jesse F, Jensen, Laura C, Smith, Keisha D, Cushing, Richard C, Seagroves, Tiffany N
Publicado 2012

Intravenous ravulizumab in mechanically ventilated patients hospitalised with severe COVID-19: a phase 3, multicentre, open-label, randomised controlled trial

por Annane, Djillali, Pittock, Sean J, Kulkarni, Hrishikesh S, Pickering, Brian W, Khoshnevis, Matt R, Siegel, Jason L, Powell, Charles A, Castro, Pedro, Fujii, Tomoko, Dunn, Derek, Smith, Keisha, Mitter, Sanjay, Kazani, Shamsah, Kulasekararaj, Austin
Publicado 2023

Bifidobacterium animalis subsp. lactis BB-12 Protects against Antibiotic-Induced Functional and Compositional Changes in Human Fecal Microbiome

por Merenstein, Daniel, Fraser, Claire M., Roberts, Robert F., Liu, Tian, Grant-Beurmann, Silvia, Tan, Tina P., Smith, Keisha Herbin, Cronin, Tom, Martin, Olivia A., Sanders, Mary Ellen, Lucan, Sean C., Kane, Maureen A.
Publicado 2021